Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Dopaminergic D-3 binding sites are not presynaptic autoreceptors

Abstract

Postsynaptic dopamine (DA) receptors have been classified biochemically and pharmacologically into two types: D-1 receptors mediate adenylate cyclase stimulation, demonstrating micromolar affinity for DA and butyrophenone antagonists; D-2 receptors mediate adenylate cyclase inhibition, demonstrating nanomolar affinity for DA and butyrophenone antagonists1,2. D-1 receptors are labelled by 3H-thioxanthene antagonists2,3, while D-2 receptors are labelled by both 3H-agonists and all 3H-antagonists2,4. A third class of dopaminergic binding site, termed D-3, represents high-affinity 3H-agonist binding sites demonstrating low, micromolar, affinity for butyrophenones5,6. In the rat striatum, D-3 sites were decreased 50% by 6-hydroxy dopamine (6-OHDA) lesions of the nigrostriatal DA pathway7–9, suggesting that such D-3 binding labels presynaptic DA autoreceptors on nigrostriatal terminals5,7–9. However, nigrostriatal denervation produces a concomitant depletion of striatal DA10,11. Here we demonstrate that a reserpine-induced depletion of DA produces a decrease in D-3 binding comparable to that seen with nigrostriatal denervation, independent of presynaptic terminal degeneration. This loss in binding, or that caused by 6-OHDA lesions, is recovered by preincubating the striatal membranes with DA or with the supernatant from control striatal membrane preparations. We therefore suggest that the loss of D-3 binding following 6-OHDA lesions results from the depletion of endogenous DA rather than the degeneration of terminals and their putatively associated autoreceptors.

This is a preview of subscription content, access via your institution

Access options

Similar content being viewed by others

References

  1. Kebabian, J. W. & Calne, D. B. Nature 277, 93–96 (1979).

    Article  ADS  CAS  Google Scholar 

  2. Creese, I., Sibley, D. R., Hamblin, M. W. & Leff, S. E. A. Rev. Neurosci. 6, 43–71 (1983).

    Article  CAS  Google Scholar 

  3. Hyttel, J. Life Sci. 23, 551–556 (1978).

    Article  CAS  Google Scholar 

  4. Hamblin, M. W. & Creese, I. Life Sci. 30, 1587–1595 (1982).

    Article  CAS  Google Scholar 

  5. Seeman, P. Pharmac. Rev. 32, 229–313 (1980).

    CAS  Google Scholar 

  6. Titeler, M., List, S. & Seeman, P. Commun. Psychopharmac. 3, 411–420 (1979).

    CAS  Google Scholar 

  7. Nagy, J. I., Lee, T., Seeman, P. & Fibiger, H. C. Nature 278, 577–578 (1978).

    Google Scholar 

  8. Sokoloff, P., Martres, M.-P. & Schwartz, J.-C. Nature 288, 283–286 (1980).

    Article  ADS  CAS  Google Scholar 

  9. Sokoloff, P., Martres, M.-P. & Schwartz, J.-C. Naunyn-Schmiedeberg's Archs Pharmak 315, 89–102 (1980).

    Article  CAS  Google Scholar 

  10. Ungerstedt, U. in 6-Hydroxydopamine and Catecholamine Neurones (eds Malmfors, T. & Thoenen, H.) 101–127 (North-Holland, Amsterdam, 1971).

    Google Scholar 

  11. Koslowski, M. R., Sawyer, S. & Marshall, J. F. Nature 287, 52–54 (1980).

    Article  ADS  Google Scholar 

  12. Munson, P. J. & Rodbard, D. Analyt. Biochem. 107, 220–239 (1980).

    Article  CAS  Google Scholar 

  13. Sibley, D. R., De Lean, A. & Creese, I. J. biol Chem. 257, 6351–6361 (1982).

    CAS  PubMed  Google Scholar 

  14. Bacopoulos, N. G. Life Sci. 29, 2407–2414 (1981).

    Article  CAS  Google Scholar 

  15. Lad, P. M., Nielsen, T. B., Preston, M. S. & Rodbell, M. J. biol. Chem. 255, 988–995 (1980).

    CAS  Google Scholar 

  16. Lefkowitz, R. J. & Williams, L. T. Proc. natn. Acad. Sci. U.S.A. 74, 515–519 (1977).

    Article  ADS  CAS  Google Scholar 

  17. Williams, L. T. & Lefkowitz, R. J. J. biol. Chem. 252, 7207–7209 (1977).

    CAS  Google Scholar 

  18. Sibley, D. R., Leff, S. E. & Creese, I. Life Sci. 31, 637–645 (1983).

    Article  Google Scholar 

  19. Nagatsu, T., Levitt, M. & Udenfriend, S. Analyt. Biochem. 9, 127–132 (1964).

    Article  Google Scholar 

  20. Knapp, S., Mandell, A. J. & Bullard, W. P. Life Sci. 16, 1583–1594 (1975).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leff, S., Creese, I. Dopaminergic D-3 binding sites are not presynaptic autoreceptors. Nature 306, 586–589 (1983). https://doi.org/10.1038/306586a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/306586a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing